Aiosyn
Aiosyn uses artificial intelligence to develop algorithms to augment pathologist with clinical decision-making. The company develops a clinical diagnostics platform with multiple AI algorithms and connect with standard pathology workflows. Aiosyn's platform will also accelerate biopharma and diagnostics companies with developing AI-based biomarker development.
Last updated on
About Aiosyn
Founded
2021Employees
11-50Funding / Mkt. Cap
$2MCategory
Location
Country
NetherlandsAiosyn
Find your buyer within Aiosyn